Brief: PDS Biotech Provides Data Update From Ongoing Versatile-002 Phase 2 Clinical Trial In Head And Neck Cancer
12/06/2024 13:10
June 12 (Reuters) - PDS Biotechnology Corp PDSB.O :
* PDS BIOTECH PROVIDES DATA UPDATE FROM ONGOING
VERSATILE-002
PHASE 2 CLINICAL TRIAL IN HEAD AND NECK CANCER
Source text for Eikon: ID:nGNX4Ts3fH
Further company coverage: PDSB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PDS Biotechnology
See all newsPDS Biotechnology Corp reports results for the quarter ended September 30 - Earnings Summary
PDS Biotechnology Q3 net loss narrows on lower R&D costs
PDS Biotechnology Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing
Brief: Pds Biotechnology Corp - On Aug 6, Approved Reduction In Force To Align Expenses With Strategic Priorities - SEC Filing